Telefon:
+49 (0)241 95 163 153
Fax:
+49 (0)241 95 163 155
E-Mail:
orders@antikoerper-online.de

Rekombinanter CEACAM6 Antikörper

Der Kaninchen Monoklonal anti-CEACAM6 Antikörper wird verwendet zum Nachweis von CEACAM6 in Proben von Human. Er wurde validiert für WB, IHC und FACS.
Produktnummer ABIN8093036
642,40 €
Zzgl. Versandkosten 20,00 € und MwSt
100 μg
Lieferung nach: Deutschland
Lieferung in 6 bis 9 Werktagen

Kurzübersicht für Rekombinanter CEACAM6 Antikörper (ABIN8093036)

Target

Alle CEACAM6 Antikörper anzeigen
CEACAM6 (Carcinoembryonic Antigen-Related Cell Adhesion Molecule 6 (CEACAM6))

Antikörpertyp

Recombinant Antibody

Reaktivität

  • 79
  • 14
  • 14
  • 1
Human

Wirt

  • 58
  • 12
  • 11
Kaninchen

Klonalität

  • 46
  • 31
  • 2
Monoklonal

Konjugat

  • 41
  • 6
  • 5
  • 5
  • 4
  • 2
  • 2
  • 2
  • 2
  • 2
  • 2
  • 2
  • 2
  • 1
  • 1
Dieser CEACAM6 Antikörper ist unkonjugiert

Applikation

  • 44
  • 31
  • 21
  • 19
  • 14
  • 13
  • 5
  • 5
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
Western Blotting (WB), Immunohistochemistry (IHC), Flow Cytometry (FACS)

Klon

CEACAM6-13372R
  • Verwendungszweck

    CEACAM6 Antibody / CD66c

    Immunogen

    Recombinant CEACAM6 protein was used as the immunogen for the CD66c/CEACAM6 antibody.

    Isotyp

    IgG, kappa
  • Applikationshinweise

    1. Optimal dilution of the CD66c/CEACAM6 antibody should be determined by the researcher.

    2. This CD66c/CEACAM6 antibody is recombinantly produced by expression in CHO cells.

    Beschränkungen

    Nur für Forschungszwecke einsetzbar
  • Format

    Liquid

    Konzentration

    0.2 mg/mL

    Buffer

    0.2 mg/mL in 1X PBS with 0.05 % BSA, 0.05 % sodium azide

    Konservierungsmittel

    Sodium azide

    Vorsichtsmaßnahmen

    This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.

    Lagerung

    -20 °C,-80 °C

    Informationen zur Lagerung

    CD66c/CEACAM6 antibody with sodium azide - store at 2 to 8oC, antibody without sodium azide - store at -20 to -80oC.
  • Target

    CEACAM6 (Carcinoembryonic Antigen-Related Cell Adhesion Molecule 6 (CEACAM6))

    Andere Bezeichnung

    CEACAM6

    Hintergrund

    CD66c antibody recognizes Carcinoembryonic antigen-related cell adhesion molecule 6, encoded by the human CEACAM6 gene. CEACAM6, also known as CD66c, NCA-90, or nonspecific cross-reacting antigen, is a glycosylphosphatidylinositol-anchored cell surface glycoprotein and a member of the carcinoembryonic antigen family within the immunoglobulin superfamily. It is predominantly localized to the plasma membrane, where it participates in cell-cell adhesion, modulation of signaling pathways, and regulation of epithelial architecture. CD66c antibody is widely used to study epithelial differentiation and tumor-associated antigen expression in a variety of tissues.

    CEACAM6 is physiologically expressed in granulocytes and in epithelial cells of the gastrointestinal tract, pancreas, and biliary system. In normal tissues, expression is typically restricted to the apical surface of epithelial cells, reflecting its role in luminal cell interactions and barrier function. Functionally, CEACAM6 contributes to intercellular adhesion and can influence intracellular signaling cascades that regulate proliferation, survival, and migration. Its overexpression has been associated with enhanced resistance to apoptosis and altered integrin-mediated signaling, supporting tumor cell survival and metastatic potential.

    In oncology research, CD66c antibody is frequently applied to evaluate CEACAM6 upregulation in colorectal carcinoma, pancreatic adenocarcinoma, gastric carcinoma, lung adenocarcinoma, and other epithelial malignancies. Increased CEACAM6 expression has been correlated with tumor progression, invasion, and poor clinical outcome in several studies. Because CEACAM6 is a surface glycoprotein with limited expression in most non-epithelial tissues, it serves as a useful marker for epithelial-derived tumors and for distinguishing specific carcinoma subtypes in diagnostic pathology research.

    Clone CEACAM6/13372R is a recombinant rabbit monoclonal antibody designed to detect CD66c expression in research applications. As a recombinant monoclonal antibody, it is produced by expression of a defined antibody sequence in cultured cells, providing batch-to-batch consistency and high specificity. A CD66c antibody such as clone CEACAM6/13372R is suitable for detecting CEACAM6 protein in immunohistochemistry, western blot, and other laboratory assays, enabling detailed investigation of epithelial biology and tumor-associated antigen expression.

    UniProt

    P40199
Sie sind hier:
Chat with us!